For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Bright Horizons Family Solutions Inc. (BFAM) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-11): Designation Low · Cairn score -17 (−100…+100 Quality+Value blend) · Quality 50 · Value -72 · Sentiment 1 (timing only, not weighted) · Composite fair value $59.14 vs $74.54 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Bright Horizons Family Solutions Inc. is a provider of early childhood education and care services, offering high-quality programs tailored to children from infancy through elementary school. The company primarily focuses on operating child care centers, providing work/life solutions, and educational advisory services. These offerings are designed to support working parents by ensuring their children receive developmental learning in a secure and nurturing environment. Bright Horizons collaborates with employers across various industries to offer customized solutions that help attract, retain, and engage employees. Additionally, the company plays a significant role in supporting working families, enhancing the balance between career and family responsibilities. As a leader in the child care service sector, Bright Horizons holds a vital position in the market by addressing the educational needs of children while simultaneously fostering employee productivity and satisfaction in the workplace.
Earnings Schedule
Checked daily · calendar updated Aug 11| Print date | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | $1.20 | $1.28 +6.7% | — | — |
| May 5, 2026 | $0.80 | $0.82 +2.5% | — | — |
| Apr 14, 2026 | $0.44 | $0.48 +9.1% | — | — |
| Feb 12, 2026 | $1.12 | $1.15 +2.7% | — | — |
| Feb 4, 2026 | $1.32 | $1.35 +2.3% | — | — |
Green = beat the estimate, red = missed. An earnings print is the fastest way a thesis changes — our designations should be re-read after each one.
Recent SEC Filings
| Filed | Form | Document |
|---|---|---|
| Aug 6, 2026 | 10-Q | View |
| Aug 4, 2026 | 3 | View |
| Aug 4, 2026 | 4 | View |
| Aug 3, 2026 | 144 | View |
| Jul 31, 2026 | SCHEDULE 13G | View |
| Jul 30, 2026 | 8-K | View |
| Jul 28, 2026 | 4 | View |
| Jun 5, 2026 | 4 | View |
| Jun 5, 2026 | 4 | View |
| Jun 5, 2026 | 4 | View |
| Jun 5, 2026 | 4 | View |
| Jun 5, 2026 | 4 | View |
Filings link to the SEC’s EDGAR system. Annual/quarterly reports (10-K, 10-Q, 20-F) carry the full story; 8-K/6-K current reports are the fastest signal that something material happened.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 3.36
Total Equity: $1.34B
Shares: 57,422,501
Total Debt: $747.61M
Cash: $140.09M
EBITDA: $408.07M
Total Debt: $747.61M
Cash: $140.09M
Revenue: $2.93B
Revenue: $2.93B
Revenue: $2.93B
Total Equity: $1.34B
Tax Rate: 28.5%
Equity: $1.34B
Total Debt: $747.61M
Cash: $140.09M
Current Liabilities: $966.17M
Long-Term Debt: $747.61M
Total Debt: $747.61M
Total Equity: $1.34B
Shares: 57,422,501
Shares: 57,422,501
CapEx: -$92.18M
Shares: 57,422,501
Stock Price: $74.54
Net Income: $193.12M
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 2, 2026 2:42pm (8d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.8B | $2.0B | $2.4B | $2.7B | $2.9B |
| Cost of Revenue | $1.3B | $1.5B | $1.9B | $2.1B | $2.2B |
| Gross Profit | $415.0M | $478.7M | $531.7M | $619.6M | $697.2M |
| Operating Expenses | $256.8M | $289.2M | $327.1M | $354.6M | $376.4M |
| Operating Income | $129.0M | $157.6M | $171.2M | $246.6M | $314.7M |
| Net Income | $70.5M | $80.6M | $74.2M | $140.2M | $193.1M |
| EBITDA | $237.8M | $263.7M | $281.9M | $344.5M | $408.1M |
| EPS | $1.16 | $1.38 | $1.28 | $2.42 | $3.39 |
| EPS (Diluted) | $1.15 | $1.37 | $1.28 | $2.40 | $3.36 |
Balance Sheet (Annual)
Last updated: Aug 2, 2026 2:22pm (8d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $261.0M | $36.2M | $71.6M | $110.3M | $140.1M |
| Total Current Assets | $540.3M | $347.7M | $446.9M | $496.0M | $504.0M |
| Total Assets | $3.6B | $3.8B | $3.9B | $3.9B | $3.9B |
| Current Liabilities | $622.2M | $786.3M | $799.4M | $779.4M | $966.2M |
| Long-Term Debt | $976.4M | $961.6M | $944.3M | $918.4M | $747.6M |
| Total Liabilities | $2.5B | $2.7B | $2.7B | $2.6B | $2.6B |
| Total Equity | $1.2B | $1.1B | $1.2B | $1.3B | $1.3B |
| Retained Earnings | $471.0M | $551.6M | $625.8M | $766.0M | $959.1M |
Cash Flow (Annual)
Last updated: Aug 2, 2026 2:42pm (8d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $227.3M | $188.5M | $256.1M | $337.5M | $350.7M |
| Capital Expenditure | -$63.5M | -$70.6M | -$91.0M | -$97.3M | -$92.2M |
| Free Cash Flow | $163.8M | $117.9M | $165.1M | $240.2M | $258.5M |
| Acquisitions (net) | -$53.9M | -$210.4M | -$39.6M | -$8.3M | -$6.8M |
| Net Debt Issued / (Repaid) | -$34.3M | $0 | $0 | -$17.0M | -$501.0M |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$213.8M | -$182.6M | $0 | -$84.6M | -$225.4M |
| Net Change in Cash | -$123.2M | -$213.4M | $37.6M | $34.3M | $19.4M |
Growth Trends (YoY %)
Last updated: Aug 2, 2026 2:42pm (8d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +15.1% | +19.7% | +11.1% | +9.2% |
| Gross Profit Growth | +15.3% | +11.1% | +16.5% | +12.5% |
| Operating Income Growth | +22.1% | +8.7% | +44.0% | +27.6% |
| Net Income Growth | +14.5% | -8.0% | +88.9% | +37.8% |
| EBITDA Growth | +10.9% | +6.9% | +22.2% | +18.4% |
Insider Trading (Recent)
Last updated: Aug 2, 2026 2:31pm (8d ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-03 | Burke Mary Lou | S-Sale | 1,200.00 | $75.57 | $90,684 |
| 2026-07-28 | Burke Mary Lou | S-Sale | 500.00 | $80.00 | $40,000 |
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Narrative Economics
market-narrative step).
Claude Reading
The raw trajectory is genuinely impressive on the surface: revenue compounded from $1.76B (2021) to $2.93B (2025), a 10.7% CAGR, while operating income more than doubled from $129M to $315M — operating margin expanded from 7.3% to 10.7%, and net income grew 2.7x. FCF hit $258.5M in 2025 vs roughly $100M pre-pandemic. That is real operating leverage, not accounting noise, and it's why the multiple isn't laughable: 11.9x EV/EBITDA and 1.65x EV/revenue for a business compounding earnings at 30%+ over multiple years is defensible if you believe the trajectory continues.
But the quarterly tape tells a more uncomfortable story that the synthesis is right to flag. Q1 2026 revenue of $712.2M is up only 7.0% YoY vs Q1 2025's $665.5M, and Q4 2025 at $733.7M was up 8.8% YoY — deceleration from the 2024 pace. More importantly, Q4 2025 net margin collapsed to 3.0% ($21.7M NI on $733.7M) versus 9.8% the prior quarter — a $57M swing in a single quarter that nobody in the prior models really interrogates. Q1 2026 recovered to 4.8%, still well below the 5.7% of Q1 2025. If you annualize the last two quarters ($55.8M NI on $1.446B rev = 3.9% margin), you get a company running materially below the 6.6% full-year 2025 net margin the market extrapolated. The 61% earnings CAGR and 37.8% recent YoY earnings growth cited in momentum are backward-looking artifacts; the forward run-rate looks more like flat-to-down earnings. That matters at 22x P/E.
I partially agree with the synthesis' "fully priced" verdict but I think the $57.63 DCF anchor is too clean — it treats the labor cost pressure as a normalized input when the Q4/Q1 margin compression suggests it's an active, unresolved problem. The thesis evaluation's -9 net score with the top bear being "labor model structurally caps margins" (weight 72) lines up with what the quarterly data actually shows. The bull case in the narrative layer — employer-paid childcare as talent-war infrastructure — is real but already priced; BFAM has been public since 2013 and this story is not new. Meanwhile, the balance sheet is unremarkable: $748M debt against $140M cash and a 0.52 current ratio is tight for a services business with fixed lease obligations, and ROA of 4.96% reveals how capital-intensive this actually is despite the "asset-light" framing. The contrarian argument I'd take seriously is different from the models': what if Q4 2025's margin dive was a one-time impairment or seasonal center opening cost, and normalized margins are closer to 8-9%? Then FCF could reach $320-350M and the stock is fairly priced, not overpriced. But there's no disclosure here confirming that, and the insider activity is pure comp awards — no open-market buys, no signal.
I dissent modestly from the synthesis' implied fair value of $57.63 (too pessimistic) but agree with the direction. My read: fair value is $62-68 based on 18x forward earnings of ~$3.60-3.75 (assuming margins normalize between the ugly Q4 print and the strong Q3), giving 10-17% downside from $74.54 rather than 23%. The recent revenue deceleration to sub-9% combined with margin volatility means the market's implicit 17% FCF growth assumption from the thesis eval is indeed too rich — but BFAM is a quality compounder with genuine employer switching costs, and quality gets a premium. This is not a short; it's a "wait for the Q2 print or a market pullback to $62 before starting a position" situation. The critical variable is whether Q4 2025's margin compression repeats in Q2 2026 — if it does, the stock has another 15% down; if margins snap back to 7-8%, the current price is defensible.
GPT Reading
Bright Horizons looks like a good business priced like a better one. The core numbers are solid: revenue has compounded from $1.76B in 2021 to $2.93B in 2025, a 13-14% annualized climb, while operating income has more than doubled from $129.0M to $314.7M. Net income reached $193.1M in 2025 versus $140.2M in 2024 and just $74.2M in 2023. Cash conversion is also real, not cosmetic: 2025 operating cash flow was $350.7M and free cash flow $258.5M after $92.2M of capex. On that basis, BFAM is not an overlevered rollup or a story stock; net debt is roughly $608M against a $3.92B equity value, and debt/equity at 0.56 is manageable. Returns are respectable for a labor-heavy operator, with 14.4% ROE and 11.6% ROIC. If I were judging only business quality, I’d say this is a credible compounder with a defensible niche.
What stands out, though, is that the margin recovery may already be doing most of the valuation work. Annual gross margin improved from 22.0% in 2023 to 23.0% in 2024 and 23.8% in 2025; operating margin moved from 7.1% to 9.2% to 10.7%; net margin from 3.1% to 5.2% to 6.6%. That is a meaningful normalization. But the quarterly pattern says this business is still not a smooth margin machine. Net margin swung from 9.8% in 2025-09 to 3.0% in 2025-12, then 4.8% in 2026-03. Revenue in the latest quarter grew a healthy 7.0% year over year to $712.2M from $665.5M, and net income rose 34.9% to $34.1M, so the business is still improving. Yet that same latest quarter also came in below the immediately preceding seasonal peak revenue levels of $802.8M and even below $733.7M in 2025-12. Seasonality is normal here, but it matters because the current multiple assumes the recovery is now durable enough to annualize. At $74.54, investors are paying about 22x earnings, 1.46x sales, and 11.9x EV/EBITDA for a company whose normalized net margin still sits in the mid-single digits and whose labor intensity inherently limits incremental margin expansion.
The key contradiction with the more optimistic read is this: the growth profile is decent, but not scarce enough to justify much premium if margins are already near a cyclical high. 2025 revenue grew 8.9% over 2024, and the latest quarter grew 7.0% year over year. That is good, not exceptional. Meanwhile, free cash flow of $258.5M equates to roughly a 6.6% FCF yield on market cap, or closer to 5.7% on enterprise value once net debt is included. For a service business with a current ratio of just 0.52, exposed to employer benefit budgets and wage inflation, that is not obviously cheap. The market seems to be valuing BFAM as if the post-2023 earnings ramp can continue at a double-digit clip while operating margins hold around 10-11% or improve further. I think that is too generous. In childcare and related services, labor is not just a cost line to optimize away; it is the product. That structurally caps upside to margins even when demand is healthy.
The strongest case against my skepticism is straightforward: BFAM has earned the right to trade above average service-sector multiples because the recovery is not just rebound noise. Revenue has increased every year since 2021, gross profit has expanded from $415.0M to $697.2M, and operating income has nearly doubled in two years from $171.2M in 2023 to $314.7M in 2025. Recent quarterly growth remains healthy, with 2026-03 revenue up 7.0% and net income up nearly 35%, which argues this is not yet stalling. If employer-sponsored childcare keeps gaining strategic importance, BFAM could continue to raise utilization and pricing without needing heroic assumptions. On that view, 22x earnings for a recurring, cash-generative, niche leader is not expensive at all, especially with net debt under control and free cash flow already over a quarter-billion dollars. I weigh that argument less heavily because the valuation no longer offers protection if growth merely stays good instead of getting better.
What would change my mind is evidence that 2025’s 10.7% operating margin is not near the ceiling. If the next few quarters show revenue sustaining 8-10% growth while net margins consistently hold above 7% outside the seasonally strongest quarter, I’d accept that the business has structurally re-rated and that $74 is reasonable. More specifically, if annual free cash flow moves from $258.5M toward $300M-plus without leverage increasing, the stock would look less stretched. Conversely, if quarterly revenue growth slips toward low single digits or net margin falls back into the 4-5% range despite continued top-line growth, the market’s willingness to pay 22x earnings should compress quickly.
Grok Reading
The annual progression is the cleanest story in the tape: revenue climbed from $1.76B in 2021 to $2.93B in 2025 at a 10.1% CAGR while operating income nearly tripled from $129M to $315M and free cash flow printed a solid $258.5M on only $92M of capex. That is real operating leverage in a labor-heavy model—net margin expanded from the mid-4s to 6.6%, ROIC reached 11.6%, and FCF conversion sits comfortably above 130% of net income. At $74.54 the stock trades at 22× trailing earnings, 11.9× EV/EBITDA and a 6.6% FCF yield on the $3.92B equity value; those multiples are not heroic for a scaled B2B services franchise that still grows high-single-digits, but they do embed continued margin expansion and mid-teens FCF growth that the recent quarterly run-rate no longer fully supports.
What stands out on the downside is the clear deceleration and seasonal margin compression that the full-year averages obscure. Q1 2026 revenue of $712M was only +7% year-on-year versus the 9–11% prints earlier in 2025, and both Q4 2025 (3.0% net margin) and Q1 2026 (4.8%) came in weaker than the prior-year winter quarters. The business remains structurally exposed to wage inflation it cannot fully pass through and to employer benefits budgets that are discretionary in a slowdown; current ratio of 0.52 and net debt of roughly $608M leave limited cushion if utilization softens. Insider activity is pure award noise—no open-market conviction either way—and the secondary flags (macro headwinds, below-sector benchmarks, decelerating revenue confidence) line up with that softening.
I therefore read the name as modestly ahead of itself rather than deeply mispriced. The prior valuation composite at ~$58 looks too punitive given the demonstrated FCF engine and the sticky employer-contract base, but the market’s implied 17% FCF compound to ~$560M inside five years is equally unrealistic for a mature earner whose labor model structurally caps operating margins near the low double digits. Fair value clusters nearer the mid-to-high $60s once growth settles into the 7–9% zone and margins stabilize rather than expand further; at $74.54 the stock is asking for the optimistic case to materialize without much margin of safety.
The strongest counter-argument is simply the multi-year evidence that Bright Horizons has already escaped the post-COVID trough: earnings CAGR of 61% off the 2023 low, operating margin back above 10%, and a recurring-revenue moat with large corporate clients that treat backup care as retention infrastructure rather than a pure cost center. A bull can fairly claim that 12× EV/EBITDA and 22× earnings understate the durability of that franchise once return-to-office and dual-income household formation re-accelerate, and that the DCF anchors used by the quantitative layer are too conservative on terminal margins. I weigh that less heavily because the most recent two quarters already show the margin rebound stalling and revenue growth rolling over—exactly the pattern you would expect if wage pressure and softer utilization are reasserting themselves.
What would flip the view is a clean re-acceleration: two consecutive quarters of ≥10% organic revenue growth with net margins holding above 7% even in the seasonally weak Q4/Q1 window, or a clear step-up in FCF above $300M that demonstrates further operating leverage is still available. Conversely, a full-year 2026 print that shows revenue growth stuck below 7% and operating margin back under 9% would confirm the stock belongs in the low $60s.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · four lenses
Bright Horizons has quietly compounded operating quality over the last five years. Revenue grew from 1.76B in 2021 to 2.93B in 2025 (roughly 13% CAGR), operating margin expanded from 7.4% to 10.7%, net income nearly tripled from 70.5M to 193.1M, and FCF rose from 163.8M to 258.5M. OCF/NI of 2.65x, accruals of -4.2% of assets, and a Beneish M of -2.63 all point to clean, cash-backed earnings with no aggressive-accounting fingerprints.
Verify before trusting this (5)
- Composition and maturity of the debt behind the 607.5M net debt figure
- Center-level utilization and pricing trends underlying the OpM expansion from 7.4% to 10.7%
- Employer-sponsorship customer concentration in the back-up care and full-service segments
- Whether the FCF step-up in 2024-2025 reflects working-capital timing or sustainable earnings power
- Capex mix (maintenance vs. new-center growth) to confirm FCF durability
The composite fair value of $59.14 (signal-adjusted $57.63) sits about 22-23% below the $74.54 price, implying negative upside of roughly -23%. The DCF ($59.64) and EPV floor ($29.43) both anchor deserved value well below the current quote; only the anchored-P/E method ($87.84) supports today's price, and that method extrapolates a recovering earnings base at a premium multiple - it should not be treated as gospel when two other methods disagree. High earnings quality (score 2) means no haircut is warranted, but it also does not close a 25% gap.
Verify before trusting this (4)
- Forward enrollment/utilization trends and center-level margin trajectory in the next 10-Q
- Management guidance for full-cycle EBITDA margin - the anchored-PE case implicitly assumes further expansion
- Any change in employer-sponsored benefit contract renewals or pricing power
- Debt paydown pace and any refinancing terms given the 607.5M net debt
The tape is mildly constructive (regime +22, VIX 16, S&P near highs) and BFAM's 1.15 beta means it participates in risk-on drift without being a high-octane vehicle. The active narrative is a moderate-intensity, moderate-durability mission-driven story with low cult coefficient - meaning there is no fervent buyer base to defend the stock, but also no crowded short thesis pressing it. Sentiment posture is neutral-to-slightly-positive going in. The freshest catalyst is materially supportive: Q2 revenue +6.5-7% to $779M, adjusted EPS +20% to $1.28, Back-up Care +19%, and a raised full-year EPS outlook. That is the kind of print that normally repairs a bruised narrative, and headlines are uniformly framed as beats and margin expansion. However, the May 6 -18.65% single-day rout on a Q1 'beat and reaffirm' is a giant sentiment scar - it tells you this name's holder base punishes anything short of a raise, and buyers remain gun-shy. Analyst tone is not shown, but no visible upgrades yet means the re-rate lift is muted. Net: a real but modest tailwind from the print offset by a still-cautious holder base and mild macro drag from 4.68% 10y on a consumer-cyclical services name trading at a premium to DCF.
Verify before trusting this (4)
- Post-print analyst target revisions and any upgrades - silence would confirm muted re-rate
- Whether Full Service occupancy trends stabilize or deteriorate through Q3
- 10y yield direction - a break above 4.8% would pressure premium-multiple services names
- Any commentary on employer-benefit renewal pricing into 2027 budget cycles
This lens hasn't been run for this ticker yet.